274 related articles for article (PubMed ID: 20072997)
1. [Genome-wide association studies in hepatology].
Weber S; Grünhage F; Hall R; Lammert F
Z Gastroenterol; 2010 Jan; 48(1):56-64. PubMed ID: 20072997
[TBL] [Abstract][Full Text] [Related]
2. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
Wasmuth HE; Lammert F; Matern S
Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
[TBL] [Abstract][Full Text] [Related]
3. A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C.
Richardson MM; Powell EE; Barrie HD; Clouston AD; Purdie DM; Jonsson JR
J Med Genet; 2005 Jul; 42(7):e45. PubMed ID: 15994870
[TBL] [Abstract][Full Text] [Related]
4. Genomics and complex liver disease: Challenges and opportunities.
Juran BD; Lazaridis KN
Hepatology; 2006 Dec; 44(6):1380-90. PubMed ID: 17133459
[TBL] [Abstract][Full Text] [Related]
5. Genetics of liver injury and fibrosis.
Weber SN; Lammert F
Alcohol Clin Exp Res; 2011 May; 35(5):800-3. PubMed ID: 21284669
[TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis: from animal models to mapping of human risk variants.
Weber SN; Wasmuth HE
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):635-46. PubMed ID: 20955966
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
Halangk J; Sarrazin C; Neumann K; Puhl G; Mueller T; Teuber G; Klinker H; Hinrichsen H; Buggisch P; Landt O; Weich V; Bergk A; Wiedenmann B; Neuhaus P; Berg T; Witt H
J Hepatol; 2008 Sep; 49(3):339-45. PubMed ID: 18644651
[TBL] [Abstract][Full Text] [Related]
8. Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients.
Sermasathanasawadi R; Kato N; Muroyama R; Dharel N; Shao RX; Chang JH; Li CZ; Kawabe T; Omata M
Liver Int; 2008 Jul; 28(6):798-806. PubMed ID: 18397234
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15.
Hillebrandt S; Goos C; Matern S; Lammert F
Gastroenterology; 2002 Dec; 123(6):2041-51. PubMed ID: 12454860
[TBL] [Abstract][Full Text] [Related]
10. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
Rudan I
Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
12. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
Huang H; Shiffman ML; Cheung RC; Layden TJ; Friedman S; Abar OT; Yee L; Chokkalingam AP; Schrodi SJ; Chan J; Catanese JJ; Leong DU; Ross D; Hu X; Monto A; McAllister LB; Broder S; White T; Sninsky JJ; Wright TL
Gastroenterology; 2006 May; 130(6):1679-87. PubMed ID: 16697732
[TBL] [Abstract][Full Text] [Related]
13. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Okamoto K; Mimura K; Murawaki Y; Yuasa I
J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease.
Daly AK; Ballestri S; Carulli L; Loria P; Day CP
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):253-63. PubMed ID: 21476920
[TBL] [Abstract][Full Text] [Related]
16. Genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans.
Weber S; Gressner OA; Hall R; Grünhage F; Lammert F
Clin Liver Dis; 2008 Nov; 12(4):747-57, vii. PubMed ID: 18984464
[TBL] [Abstract][Full Text] [Related]
17. Liver fibrogenesis and genetic factors.
Boursier J; Louvet A
Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S3-9. PubMed ID: 21742298
[TBL] [Abstract][Full Text] [Related]
18. The pursuit of genome-wide association studies: where are we now?
Ku CS; Loy EY; Pawitan Y; Chia KS
J Hum Genet; 2010 Apr; 55(4):195-206. PubMed ID: 20300123
[TBL] [Abstract][Full Text] [Related]
19. Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.
Asselah T; Bièche I; Paradis V; Bedossa P; Vidaud M; Marcellin P
Semin Liver Dis; 2007 Feb; 27(1):13-27. PubMed ID: 17295174
[TBL] [Abstract][Full Text] [Related]
20. Genetic studies to identify hepatic fibrosis genes and SNPs in human populations.
Day CP
Methods Mol Med; 2005; 117():315-31. PubMed ID: 16118460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
